The psychedelic drug industry already has a large footprint in healthcare. And it is growing in literally every direction.
Articles
Novamind Reports Fiscal Q3 Financial Results and Operating Highlights
Novamind's clinic revenues jumped 43% quarter-over-quarter, to CAD$1.85 million. Projecting a 225% increase in clinic visits year-over-year.
Bill to Legalize Psilocybin Therapy Introduced in Maine
A bill filed in Maine would legalize psilocybin mushroom therapy without a medical diagnosis, and allow adults 21-and-older to legally buy the psychedelic and use it under the supervision of a certified psilocybin service practitioner, according to the Dales Report.
This is why psilocybin may be able to help millions
It may only be a matter of time before psychedelics become a go-to treatment for millions suffering with some sort of mental illness.
Bill To Federally Legalize Marijuana Reintroduced In Congress As Senate Prepares Separate Measure
A bill to federally legalize marijuana and promote social equity in the industry was reintroduced in the House.
New Analysis Shows Tax Revenue From Cannabis In The Billions
States that have legalized adult-use marijuana sales have seen billions of dollars in fresh tax revenue from cannabis.
New Analysis Shows Tax Revenue From Cannabis In The Billions
A recently published study shows the significant potential legalization has in terms of tax revenue from cannabis sales.
Adult-Use Legalization Has Led to $7.9B in Tax Revenues for States
Adult-use cannabis legalization in the U.S. has generated billions in tax revenue for the states that have passed the reforms.
Texas Closer to Passing Bill That Studies Medicinal Psychoactive Drugs
The bill passed 6-0 and has garnered bipartisan support.
Marijuana Industry Expected to Add $92 Billion to U.S. Economy in 2021
From jobs to tax revenue to commercial real estate, the marijuana industry has a large – and growing – impact on the broader economy in the United States.
Health Official Touts Psilocybin's’ Therapeutic Benefits
A top U.S. health official on Wednesday touted the therapeutic potential of psychedelics like psilocybin and MDMA.
Mental Health Care May Never be the Same With Biotech
There’s been a substantial proof psychedelics can help with issues such as depression, anxiety, addiction, obsessive compulsive disorder, and obesity.
Louisiana Marijuana Decriminalization Bill Advances To Senate Floor, One Step From Governor’s Desk
A bill to decriminalize marijuana possession in Louisiana that already passed the House was approved in a Senate committee on Tuesday, sending it to the full chamber for final passage.
Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms
Mydecine receives regulatory approval to expand its psilocybin mushroom cultivation operations.
Shroom boom?
Research is proving the potential psychedelics hold when it comes to healing mental health. Now, investors are looking to cash in.